GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $20,000 | +100.0% | 94 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $10,000 | +11.1% | 94 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $9,000 | -18.2% | 94 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $11,000 | +37.5% | 94 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $8,000 | -11.1% | 94 | +5.6% | 0.00% | 0.0% |
Q4 2019 | $9,000 | -10.0% | 89 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $10,000 | -44.4% | 89 | -16.0% | 0.00% | -50.0% |
Q2 2019 | $18,000 | +5.9% | 106 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $17,000 | +41.7% | 106 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $12,000 | +100.0% | 106 | +202.9% | 0.00% | 0.0% |
Q3 2018 | $6,000 | +50.0% | 35 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | +33.3% | 35 | 0.0% | 0.00% | – |
Q1 2018 | $3,000 | -25.0% | 35 | 0.0% | 0.00% | – |
Q4 2017 | $4,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q3 2017 | $4,000 | – | 35 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |